Chiara Contri

6PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Characterisation of biological macromoleculesBiologically active moleculesPredictive and prognostic markersAutonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 28, 2026
In Vitro Radiobiological Evaluation of [64Cu]CuCl2 for Theranostic Applications.

|Apr 12, 2024
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence.

Annalida Bedini, Gian Marco Elisi, Fabiola Fanini

|Sep 28, 2023
Pharmacology of Adenosine Receptors: Recent Advancements.

Fabrizio Vincenzi, Silvia Pasquini, Chiara Contri

|Jun 28, 2023
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target?

Stefania Merighi, Alessia Travagli, Manuela Nigro

|Feb 15, 2022
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets.

Silvia Pasquini, Chiara Contri, Stefania Merighi

|Feb 15, 2022
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition.

Alessandro Papa, Silvia Pasquini, Chiara Contri

Pageof 1

Frequent Collaborators

6 joint publications

Silvia Pasquini

6 joint publications

Katia Varani

6 joint publications

Fabrizio Vincenzi

3 joint publications

Stefania Merighi